Mimetas raised €16M in a Series B round in Feb 2018. The company is based in Leiden, Netherlands. Investors in the round: Aglaia Oncology Fund II, Cathay Venture, European Life Sciences Growth Fund and 3 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
